Wen-Bin Zhao (Wenbin Zhao)

ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 11

Top Venues

Biomedicines

Science advances

International journal of molecular sciences

Cancers

Zhejiang University (PHD)

This page only lists publications with an associated author ORCID identifier.

Education History

Zhejiang University Sep 01 2014

China

PHD :: College of Pharmaceutial Science

Publications

Li Lu, Mingqi Xie, Bo Yang, Wen-Bin Zhao, Ji Cao
Enhancing the safety of CAR-T cell therapy: Synthetic genetic switch for spatiotemporal control. Science advances 10 (8) (2024)
Li Lu, Mingqi Xie, Bo Yang, Wen-Bin Zhao, Ji Cao
Enhancing the safety of CAR-T cell therapy: Synthetic genetic switch for spatiotemporal control. Science advances 10 (8) (2024)
Yiming Li, Wen-Bin Zhao, Ying Shen, Yingchun Xu, Rongchang Chen, Liqiang Pan
T Cell Receptor-Directed Bispecific T Cell Engager Targeting MHC-Linked NY-ESO-1 for Tumor Immunotherapy. Biomedicines 12 (4) (2024)
Li Lu, Mingqi Xie, Bo Yang, Wen-Bin Zhao, Ji Cao
Enhancing the safety of CAR-T cell therapy: Synthetic genetic switch for spatiotemporal control. Science advances 10 (8) (2024)
Yiming Li, Wen-Bin Zhao, Ying Shen, Yingchun Xu, Rongchang Chen, Liqiang Pan
T Cell Receptor-Directed Bispecific T Cell Engager Targeting MHC-Linked NY-ESO-1 for Tumor Immunotherapy. Biomedicines 12 (4) (2024)
Yi-Sheng Sun, Jing-Jing Zhou, Han-Ping Zhu, Fang Xu, Wen-Bin Zhao, Hang-Jing Lu, Zhen Wang, Rongchang Chen, Ping-Ping Yao, Jian-Min Jiang, Zhan Zhou
Development of a Recombinant RBD Subunit Vaccine for SARS-CoV-2. Viruses 13 (10) (2021)
Xuefei Bai, Wenhui Liu, Shijie Jin, Wen-Bin Zhao, Yingchun Xu, Zhan Zhou, Rongchang Chen, Liqiang Pan
Facile Generation of Potent Bispecific Fab via Sortase A and Click Chemistry for Cancer Immunotherapy. Cancers 13 (18) (2021)
Wen-Bin Zhao, Ying Shen, Wen-Hui Liu, Yi-Ming Li, Shi-Jie Jin, Ying-Chun Xu, Li-Qiang Pan, Zhan Zhou, Rongchang Chen
Soluble Expression of Fc-Fused T Cell Receptors Allows Yielding Novel Bispecific T Cell Engagers. Biomedicines 9 (7) (2021)
Chi-Xiao Qiu, Xue-Fei Bai, Ying Shen, Zhan Zhou, Li-Qiang Pan, Ying-Chun Xu, Wen-Bin Zhao, Shu-Qing Chen
Specific Inhibition of Tumor Growth by T Cell Receptor-Drug Conjugates Targeting Intracellular Cancer-Testis Antigen NY-ESO-1/LAGE-1. Bioconjugate chemistry 31 (12) (2020)
Ying Shen, Yi-Ming Li, Jing-Jing Zhou, Zhan Zhou, Ying-Chun Xu, Wen-Bin Zhao, Rongchang Chen
The Antitumor Activity of TCR-Mimic Antibody-Drug Conjugates (TCRm-ADCs) Targeting the Intracellular Wilms Tumor 1 (WT1) Oncoprotein. International journal of molecular sciences 20 (16) (2019)
Ying Xu, Shijie Jin, Wen-Bin Zhao, Wenhui Liu, Ding Ding, Jie Zhou, Shuqing Chen
A Versatile Chemo-Enzymatic Conjugation Approach Yields Homogeneous and Highly Potent Antibody-Drug Conjugates. International journal of molecular sciences 18 (11) (2017)

Wen-Bin Zhao.css-eqlu8i{font-size:small;padding-left:4px;} (Wenbin Zhao)

Publication Activity (10 Years)

Top Topics

Top Venues

Wen-Bin Zhao (Wenbin Zhao)